Clinical Trial Update: Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tranilast alone or in combination with febuxostat in patients with gout and hyperuricemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• FEBUXOSTAT (Febuxostat)
• Tranilast (tranilast)

Snippet

Sponsor: Nuon Therapeutics, Inc. | Conditions: Gout, Hyperuricemia | Phase 2 | Status: COMPLETED